Zoetis (ZTS) Research & Development (2012 - 2026)

Zoetis (ZTS) has 13 years of Research & Development data on file, last reported at $180.0 million in Q1 2026.

• Research & Development for Q1 2026 came in at $180.0 million, up 11.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $721.0 million (up 5.1% YoY), and the FY2025 annual result was $698.0 million, up 1.75% from the prior year.
• Research & Development declined to $180.0 million in Q1 2026 per ZTS's latest filing, from $199.0 million in the prior quarter.
• Over five years, Research & Development peaked at $199.0 million in Q4 2025 and troughed at $122.0 million in Q1 2022.
• A 5-year average of $160.1 million and a median of $162.0 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2023 and 2025: Research & Development advanced 17.57% in 2023, then changed 0.0% in 2025.
• A 5-year view of Research & Development shows it stood at $148.0 million in 2022, then grew by 17.57% to $174.0 million in 2023, then gained by 6.9% to $186.0 million in 2024, then rose by 6.99% to $199.0 million in 2025, then fell by 9.55% to $180.0 million in 2026.
• Business Quant data shows ZTS's Research & Development at $180.0 million in Q1 2026, $199.0 million in Q4 2025, and $170.0 million in Q3 2025.